IL10 and pulmonary fibrosis: Since it has been demonstrated that DCSL1 alleviates fibrosis and increases IL-10 levels in the bleomycin-induced lung fibrosis model in young mice [16], we tested the hypothesis that it could have the same efficacy in the aging heart.